Khandani Amir H, Isasi Carmen R, Donald Blaufox M
Department of Nuclear Medicine, Montefiore Medical Center & Albert Einstein College of Medicine, New York, USA.
Nucl Med Commun. 2005 Sep;26(9):787-91. doi: 10.1097/01.mnm.0000175264.33368.da.
To measure the variability of cardiac uptake on serial whole-body F-FDG PET scans.
Two hundred and eighteen whole-body PET scans were performed in 47 patients with different primary malignancies between October 1996 and April 2003 on a dedicated PET system. The number of scans per patient ranged between four and nine. Two experienced nuclear medicine physicians reviewed the scans retrospectively using the non-attenuation corrected images to assess the cardiac FDG uptake. Patients with cardiac uptake less or equal to lung uptake were assigned in the "low" uptake group, and those with cardiac uptake more than the lung uptake were assigned to the "high" uptake group. The reproducibility of cardiac uptake on serial whole-body PET scans and the effect of age, sex, weight, diabetes and primary diagnosis on cardiac uptake was evaluated.
There was very good reproducibility (intra-class correlation coefficient=0.77) of individual cardiac FDG uptake on serial whole-body PET scans. Diabetics (n=6) in comparison to non-diabetics were less likely to have high cardiac uptake (odds ratio (OR)=0.24, P<0.05). Patients with lymphoma (n=12) in comparison to patients with other primary diagnoses were more likely to have high cardiac uptake (OR=8.6, P<0.05). There was no association between cardiac uptake and age, sex or weight.
Cardiac FDG uptake on whole-body PET does not appear to change significantly over time. It is likely that uptake is determined by individual characteristics; these likely include diabetes and primary diagnosis of lymphoma.
测量连续全身F-FDG PET扫描中心脏摄取的变异性。
1996年10月至2003年4月期间,在一台专用PET系统上对47例患有不同原发性恶性肿瘤的患者进行了218次全身PET扫描。每位患者的扫描次数在4至9次之间。两名经验丰富的核医学医师使用未进行衰减校正的图像对扫描结果进行回顾性分析,以评估心脏FDG摄取情况。心脏摄取低于或等于肺部摄取的患者被归入“低”摄取组,而心脏摄取高于肺部摄取的患者被归入“高”摄取组。评估了连续全身PET扫描中心脏摄取的可重复性以及年龄、性别、体重、糖尿病和原发性诊断对心脏摄取的影响。
连续全身PET扫描中个体心脏FDG摄取具有非常好的可重复性(组内相关系数=0.77)。与非糖尿病患者相比,糖尿病患者(n=6)出现高心脏摄取的可能性较小(优势比(OR)=0.24,P<0.05)。与其他原发性诊断的患者相比,淋巴瘤患者(n=12)出现高心脏摄取的可能性更大(OR=8.6,P<0.05)。心脏摄取与年龄、性别或体重之间无关联。
全身PET检查中,心脏FDG摄取似乎不会随时间发生显著变化。摄取情况可能由个体特征决定;这些特征可能包括糖尿病和淋巴瘤的原发性诊断。